Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04167436
Other study ID # REG-040-2017
Secondary ID
Status Recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date May 1, 2019
Est. completion date August 1, 2022

Study information

Verified date February 2022
Source Zealand University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized clinical trial of multimodal prehabilitation in vulnerable patients with colon or rectal cancer prior to surgery.


Description:

Fit for surgery is a randomized clinical trial of multimodal prehabilitation prior to colon or rectal cancer surgery. Participants will either receive The study is a part of the PREHAB study which is performed in collaboration with international centers. The full protocol are published BMC Cancer. 2019 Jan 22;19(1):98. doi: 10.1186/s12885-018-5232-6.


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date August 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Undergoing elective colorectal cancer surgery - WHO performance status I and II - Signed consent Exclusion Criteria: - Known metastatic disease - Unable to perform baseline test or basic training e.g. paralytic or completely immobilized patients, orthopedic impairments. - ASA 4 or 5 (American Society of Anesthesiologist Classification) - Neoadjuvant chemo- or radiation therapy - Renal failure III B or higher - Illiteracy or unable to write or understand Danish - Cognitive disabilities, which affects adherence e.g. severe dementia (MMSE score =17). - Withdrawal of consent.

Study Design


Intervention

Other:
Prehabilitation
A minimum of four weeks of prehabilitation with exercise three times a week, protein and vitamin supplements, dietitian consultation and medical optimization prior to surgery.

Locations

Country Name City State
Denmark Zealand University Hospital Køge Danmark
Denmark Slagelse Hospital Slagelse Danmark

Sponsors (1)

Lead Sponsor Collaborator
Zealand University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Recovery 15 Difference in postoperative recovery between baseline and within 3 days after surgery. The cumulative score ranges from 0-150, with a higher value indicating a better outcome 3 days after surgery
Primary Changes in physical fitness prior to surgery Changes in VO2 max between baseline and prior to surgery Baseline, prior to surgery and 30 days after surgery
Primary Complications Complications measured by the comprehensive complication index. The score ranges from 0-100 with with a higher value indicating a worse outcome. 30 days after surgery
Primary Changes in immunological function Changes in immunological function measured by nanostring in blood and tumor (in the invasive front) Blood work taken at baseline, prior to surgery, three days after surgery and four weeks after surgery. Tumor from resectionspecimen
Secondary Disease specific quality of life - EORTC c30 European Organisation for Research and Treatment of Cancer Questionaire c 30 (EORTC c30). The EORTC c30 contains 6 domains which will each be assessed for mean changes in their cumulative score. The domains are physical function, role function, emotional function, pain, fatigue and global health. A higher value indicating a worse outcome the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Secondary Disease specfic quality of life - EORTC c29 European Organisation for Research and Treatment of Cancer Questionaire c 29 (EORTC). The questionnaire contains 29 items, with a 4 point Likert scale for symptoms and 7 point Likert scale for quality of life and global health. For the 4 point Likert scale the higher the score the worse the outcome. For the 7 point likert scale higher values indicating a better outcome. Analysis will be performed for changes in individual symptoms and cumulative aggregation of scores will not be performed. the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Secondary Overall quality of life - SF-36 Short Form 36 question (SF-36) health questionnaire. The questionnaire contains eight domains: physical functioning, pain, limitations due to physical health problems, limitations due to personal or emotional problems, emotional well-being, social functioning, fatigue, and general health perceptions. Scores for each domain range from 0 to 100 and the analysis will be performed as mean difference between baseline and the following time frame. A higher value indicating a better outcome. the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Secondary Psychological health - Depression - PHQ-9 Patient Health Questionnaire 9 (PHQ-9) Depression test. The PHQ-9 have a maximum of 27 points and a minimum of 0. The outcome is point change between baseline and following time frame. A higher value indicating a worse outcome the day prior to surgery,30 days after surgery, 60 days after surgery and one year after surgery
Secondary Psychological health - General anxiety - GAD-7 General Anxiety Disorder 7-item (GAD-7). The questionnaire have a maximum of 21 points and a minium of 0. The outcome is the point change between baselin and the following time frame. A higher value indicating a worse outcome the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Secondary Physical function (6-MWT) 6-Minutes walk test. Measures how far the participant can walk in 6 minutes measured in meters The day prior to surgery, 30 days after surgery, and 60 days after surgery
Secondary Physical function (STS) Sit-to-stand test. Test of how many times the patient can rise from a chair in 30 seconds. The day prior to surgery, 30 days after surgery, and 60 days after surgery.
Secondary Physical function (Stair climb test) Stair climb test will be measured as the number of steps (17 mc in height) the paitent can rise in 30 secounds. The day prior to surgery, 30 days after surgery, and 60 days after surgery
Secondary Physical function (Leg extension test) Leg extension test will be measured by fixed dynaometer in newtons three times on each leg and the maximum for each leg used for analysis. The day prior to surgery, 30 days after surgery, and 60 days after surgery
Secondary Physical function (Hand grip strength) Hand grip strength measured by hand-held dynanometer in kilograms. Measured 3 times on each hand and will use the maximum obtained. The day prior to surgery, 30 days after surgery, and 60 days after surgery
Secondary Nutritional status Increase/decrease in total body weight in percent. The day prior to surgery, 30 days after surgery, and 60 days after surgery
Secondary Remission and cancer free survival Remission and cancer free survival 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A